Project Grant 2322443
Award Date
1/15/24
Completion Date
9/30/24
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Awardee
Mellicell Inc. (EFGLLLKFX2S7)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Newtonville, MA 02458, USA
Similar Awards
This federal Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to develop a novel adipocyte engineering technology for modeling adipocyte dysfunction in human obesity. The $295,923 award to Mellicell Inc., a for-profit organization located in Newtonville, MA, will support two key milestones. Milestone 1 will compare the differentiation,...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $1,000,000 aims to demonstrate the safety and tolerability of a novel "living pharmacy" organism as a treatment for diabetes and obesity in cats. The project plans to show that a single injection can control blood glucose and weight gain for 12 weeks or longer, with the eventual goal of entering the human market. The award was made to Simmbion LLC, a small...
This National Science Foundation (NSF) SBIR Phase I award to Foragr Medicines, Inc. provides $275,000 to develop a high-throughput platform for small molecule targeting of undruggable proteins via their mRNAs. The project aims to create an efficient and cost-effective approach to discover new therapeutics for previously untreatable diseases, including neurodegenerative conditions and aggressive cancers. Key innovations include automating ligand screening against mRNA targets and enabling...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant of $274,829 awarded to Rosebud Biosciences Inc. on August 15, 2023 aims to enable the development of new therapies for rare diseases in children. The project objectives are to: (1) Automate the derivation of heart, liver, and brain organoids from human stem cells, and (2) Develop automated machine learning models to detect disease phenotypes in these organoids derived from patients with...
This award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $303,864 to Core Biotherapeutics Inc., a for-profit organization, to develop a platform for designing disruptive drug candidates that can address high unmet medical needs. The project aims to determine the biological laws governing molecular networks that drive diseases and program these into an efficient, scalable algorithm for drug target discovery. This...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award, valued at $550,000 and dated August 15, 2024, supports the development of a novel label-free and non-invasive microwave system for rapidly measuring and selecting high-performing, highly stable Chinese Hamster Ovary (CHO) cells. The project involves creating an automated microwave system for comprehensive single-cell measurement, characterizing a variety of CHO cells, developing...
This $600,000 Project Grant award from the National Science Foundation's Division of Information and Intelligent Systems (CFDA #47.070 - Computer and Information Science and Engineering) supports the Massachusetts Institute of Technology (MIT) in developing a cyber physical system to remotely control cellular processes and create synthetic pancreatic tissue. The research aims to overcome challenges in recreating complex 3D tissue structures by using swarms of microrobots to regulate the...
This $294,947 Project Grant awarded by the National Science Foundation (NSF) under its Technology, Innovation, and Partnerships (CFDA 47.084) program will fund the development of a software tool to automate the creation of drug repurposing development plans. The tool aims to address the challenges and inefficiencies in the current manual process of generating these regulatory plans, which is often time-consuming and error-prone. The proposed solution leverages advances in natural language...
This $274,991 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a new approach to deliver cancer-killing proteins specifically to acute myeloid leukemia (AML) cells while sparing healthy cells. The project aims to engineer natural killer (NK) cells with targeted protein degraders (TPDs) against three common AML driver proteins, with the goal of demonstrating...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Seia Bio Inc. aims to develop a generalized process for formulating and stabilizing beneficial microbes to enable their widespread commercial adoption. The proposed R&D will advance the understanding of microbial protection against common stressors like heat, UV-light, shock, and humidity, by measuring physicochemical properties and viability. This innovative...